CBPO [China Biologic Products] 6-K: FOR RELEASE August 3, 2018 China Biologic Reports

[FOR RELEASE August 3, 2018 China Biologic Reports Financial Results for the Second Quarter of 2018 --2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.8% YoY in RMB terms, or Total Sales Up 34.8% YoY to $120.4 Million and Net Income Down 7.7% YoY to $28.6 Million in USD terms— --]

OIIM [O2MICRO INTERNATIONAL] 6-K: (Original Filing)

[O2Micro Reports Second Quarter 2018 Financial Results GEORGE TOWN, Grand Cayman, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Operational and Strategic Highlights: Q2 2018 results were within the range of guidance provided in May 2018. GAAP net income per fully diluted ADS in the second quarter of 2018 was 6 c]

By | 2018-08-04T03:30:49+00:00 August 3rd, 2018|Categories: Chinese Stocks, OIIM, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar